Pfizer Buys Seagen For $43b, Expands Cancer Research
Seagen, formerly known as Seattle Genetics, specializes in developing cancer therapies like Adcetris — a drug used to treat Hodgkin's lymphoma.
Source: scrippsnews.com
Stay updated with breaking news from David Epstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Seagen, formerly known as Seattle Genetics, specializes in developing cancer therapies like Adcetris — a drug used to treat Hodgkin's lymphoma.
Washington: US pharmaceutical giant Pfizer announced on Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cance...
Approaching nor’easter is expected to bring heavy snow, rain, strong winds, and power outages beginning Monday night. Read on Boston.com.
Breaking News Headlines Today